Skip to main content
NCBI home page
Gut logoLink to Gut
. 1996 Nov;39(5):654–660. doi: 10.1136/gut.39.5.654

Aspirin related gastrointestinal bleeders have an exaggerated bleeding time response due to aspirin use.

A I Lanas 1, M T Arroyo 1, F Esteva 1, R Cornudella 1, B I Hirschowitz 1, R Sáinz 1
PMCID: PMC1383387  PMID: 9026478

Abstract

BACKGROUND: Gastrointestinal bleeding is related to non-steroidal anti-inflammatory drug (NSAID) use, especially aspirin, but only a small subset of users bleed. AIM: To look for risk factors or mechanisms whereby aspirin may promote gastrointestinal bleeding. PATIENTS: Sixty one patients with previous aspirin related upper gastrointestinal bleeding and 61 matched controls. METHODS: Patients and controls were given 375 mg of aspirin and sequential skin bleeding time and blood aspirin levels were measured. Additional studies included platelet lumiaggregation, von Willebrand factor, Factor VIII, and coagulation studies. RESULTS: Baseline skin bleeding time was similar in bleeders and controls, but bleeders had a more prolonged skin bleeding time after aspirin use. Hyper-response was more frequent in bleeders (30% v 9.3%; p < 0.01) and was associated with more than one previous separate bleeding event and a lower packed cell volume during the preceding bleeding episode. No differences were found in other factors studied. Logistic regression analysis identified prolonged skin bleeding time after aspirin use as an independent factor contributing to aspirin related gastrointestinal bleeding (RR = 5.4; 95% CI: 1.8 to 17.1). CONCLUSIONS: 30% of patients with a history of aspirin related gastrointestinal bleeding have an exaggerated prolongation of skin bleeding time in response to aspirin, which may be a risk factor for bleeding. This intrinsic defect or to subclinical von Willebrand disease or different aspirin metabolism.

Full text

PDF
654

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allison M. C., Fullarton G. M., Brown I. L., Crean G. P., McColl K. E. Enhanced gastric mucosal haemostasis after upper gastrointestinal haemorrhage. Gut. 1991 Jul;32(7):735–739. doi: 10.1136/gut.32.7.735. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bakar S. K., Niazi S. High-performance liquid chromatographic determination of aspirin and its metabolites in plasma and urine. J Pharm Sci. 1983 Sep;72(9):1020–1023. doi: 10.1002/jps.2600720913. [DOI] [PubMed] [Google Scholar]
  3. Bang C. J., Riedel B., Talstad I., Berstad A. Interaction between heparin and acetylsalicylic acid on gastric mucosal and skin bleeding in humans. Scand J Gastroenterol. 1992 Jun;27(6):489–494. doi: 10.3109/00365529209000110. [DOI] [PubMed] [Google Scholar]
  4. Barber A., Green D., Galluzzo T., Ts'ao C. H. The bleeding time as a preoperative screening test. Am J Med. 1985 May;78(5):761–764. doi: 10.1016/0002-9343(85)90280-3. [DOI] [PubMed] [Google Scholar]
  5. Bick R. L., Adams T., Schmalhorst W. R. Bleeding times, platelet adhesion, and aspirin. Am J Clin Pathol. 1976 Jan;65(1):69–72. doi: 10.1093/ajcp/65.1.69. [DOI] [PubMed] [Google Scholar]
  6. Buchanan G. R., Holtkamp C. A. A comparative study of variables affecting the bleeding time using two disposable devices. Am J Clin Pathol. 1989 Jan;91(1):45–51. doi: 10.1093/ajcp/91.1.45. [DOI] [PubMed] [Google Scholar]
  7. Connor A. M., Laposata M. A rapid assay for platelet thromboxane production and its use in assessing prior aspirin ingestion. Am J Clin Pathol. 1988 Feb;89(2):216–221. doi: 10.1093/ajcp/89.2.216. [DOI] [PubMed] [Google Scholar]
  8. Day J. P., Lanas A., Rustagi P., Hirschowitz B. I. Reversible prolonged skin bleeding time in acute gastrointestinal bleeding presumed due to NSAIDs. J Clin Gastroenterol. 1996 Mar;22(2):96–103. doi: 10.1097/00004836-199603000-00004. [DOI] [PubMed] [Google Scholar]
  9. Deykin D., Janson P., McMahon L. Ethanol potentiation of aspirin-induced prolongation of the bleeding time. N Engl J Med. 1982 Apr 8;306(14):852–854. doi: 10.1056/NEJM198204083061406. [DOI] [PubMed] [Google Scholar]
  10. Faulkner G., Prichard P., Somerville K., Langman M. J. Aspirin and bleeding peptic ulcers in the elderly. BMJ. 1988 Nov 19;297(6659):1311–1313. doi: 10.1136/bmj.297.6659.1311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Fiore L. D., Brophy M. T., Lopez A., Janson P., Deykin D. The bleeding time response to aspirin. Identifying the hyperresponder. Am J Clin Pathol. 1990 Sep;94(3):292–296. doi: 10.1093/ajcp/94.3.292. [DOI] [PubMed] [Google Scholar]
  12. Gabriel S. E., Jaakkimainen L., Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med. 1991 Nov 15;115(10):787–796. doi: 10.7326/0003-4819-115-10-787. [DOI] [PubMed] [Google Scholar]
  13. Gaspari F., Viganò G., Orisio S., Bonati M., Livio M., Remuzzi G. Aspirin prolongs bleeding time in uremia by a mechanism distinct from platelet cyclooxygenase inhibition. J Clin Invest. 1987 Jun;79(6):1788–1797. doi: 10.1172/JCI113020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hirsh J., Street D., Cade J. F., Amy H. Relation between bleeding time and platelet connective tissue reaction after aspirin. Blood. 1973 Mar;41(3):369–377. [PubMed] [Google Scholar]
  15. Kumar R., Ansell J. E., Canoso R. T., Deykin D. Clinical trial of a new bleeding-time device. Am J Clin Pathol. 1978 Oct;70(4):642–645. doi: 10.1093/ajcp/70.4.642. [DOI] [PubMed] [Google Scholar]
  16. Kurata J. H., Abbey D. E. The effect of chronic aspirin use on duodenal and gastric ulcer hospitalizations. J Clin Gastroenterol. 1990 Jun;12(3):260–266. doi: 10.1097/00004836-199006000-00005. [DOI] [PubMed] [Google Scholar]
  17. Lanas A., Sekar M. C., Hirschowitz B. I. Objective evidence of aspirin use in both ulcer and nonulcer upper and lower gastrointestinal bleeding. Gastroenterology. 1992 Sep;103(3):862–869. doi: 10.1016/0016-5085(92)90018-t. [DOI] [PubMed] [Google Scholar]
  18. Langman M. J. Ulcer complications and nonsteroidal anti-inflammatory drugs. Am J Med. 1988 Feb 22;84(2A):15–19. doi: 10.1016/0002-9343(88)90249-5. [DOI] [PubMed] [Google Scholar]
  19. Langman M. J., Weil J., Wainwright P., Lawson D. H., Rawlins M. D., Logan R. F., Murphy M., Vessey M. P., Colin-Jones D. G. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet. 1994 Apr 30;343(8905):1075–1078. doi: 10.1016/s0140-6736(94)90185-6. [DOI] [PubMed] [Google Scholar]
  20. McCarthy D. M. Nonsteroidal anti-inflammatory drugs--the clinical dilemmas. Scand J Gastroenterol Suppl. 1992;192:9–16. doi: 10.3109/00365529209095974. [DOI] [PubMed] [Google Scholar]
  21. Mielke C. H., Jr, Kaneshiro M. M., Maher I. A., Weiner J. M., Rapaport S. I. The standardized normal Ivy bleeding time and its prolongation by aspirin. Blood. 1969 Aug;34(2):204–215. [PubMed] [Google Scholar]
  22. Nieuwenhuis H. K., Akkerman J. W., Sixma J. J. Patients with a prolonged bleeding time and normal aggregation tests may have storage pool deficiency: studies on one hundred six patients. Blood. 1987 Sep;70(3):620–623. [PubMed] [Google Scholar]
  23. Nyman I., Larsson H., Wallentin L. Prevention of serious cardiac events by low-dose aspirin in patients with silent myocardial ischaemia. The Research Group on Instability in Coronary Artery Disease in Southeast Sweden. Lancet. 1992 Aug 29;340(8818):497–501. doi: 10.1016/0140-6736(92)91706-e. [DOI] [PubMed] [Google Scholar]
  24. O'Laughlin J. C., Hoftiezer J. W., Mahoney J. P., Ivey K. J. Does aspirin prolong bleeding from gastric biopsies in man? Gastrointest Endosc. 1981 Feb;27(1):1–5. doi: 10.1016/s0016-5107(81)73131-6. [DOI] [PubMed] [Google Scholar]
  25. Silagy C. A., McNeil J. J., Donnan G. A., Tonkin A. M., Worsam B., Campion K. Adverse effects of low-dose aspirin in a healthy elderly population. Clin Pharmacol Ther. 1993 Jul;54(1):84–89. doi: 10.1038/clpt.1993.115. [DOI] [PubMed] [Google Scholar]
  26. Stuart M. J., Miller M. L., Davey F. R., Wolk J. A. The post-aspirin bleeding time: a screening test for evaluating haemostatic disorders. Br J Haematol. 1979 Dec;43(4):649–659. doi: 10.1111/j.1365-2141.1979.tb03798.x. [DOI] [PubMed] [Google Scholar]
  27. Stuart M. J., Miller M. L., Davey F. R., Wolk J. A. The post-aspirin bleeding time: a screening test for evaluating haemostatic disorders. Br J Haematol. 1979 Dec;43(4):649–659. doi: 10.1111/j.1365-2141.1979.tb03798.x. [DOI] [PubMed] [Google Scholar]
  28. Whittle B. J., Kauffman G. L., Jr, Moncada S. Hemostatic mechanisms, independent of platelet aggregation, arrest gastric mucosal bleeding. Proc Natl Acad Sci U S A. 1986 Aug;83(15):5683–5687. doi: 10.1073/pnas.83.15.5683. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Willard J. E., Lange R. A., Hillis L. D. The use of aspirin in ischemic heart disease. N Engl J Med. 1992 Jul 16;327(3):175–181. doi: 10.1056/NEJM199207163270308. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES